New York, New York--(Newsfile Corp. - January 5, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visit ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Alexandria Real Estate Equities, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Alexandria Real Estate Equities securities between January 27, 2025, and October 27, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 26, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [7]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Background - The lawsuit alleges that defendants provided misleading information regarding Alexandria Real Estate's expected revenue and funds from operations growth for the 2025 fiscal year, particularly concerning its real estate operations [5]. - Defendants reportedly made positive statements about Alexandria Real Estate's lease activity and occupancy stability while concealing adverse facts about the true state of its Long Island City property [6].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - Alexandria Real Estate reported lower-than-expected results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on consecutive days [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. Legal Proceedings - Investors have until January 26, 2026, to request to lead the case in the U.S. District Court for the Central District of California, under the caption Hern v. Alexandria Real Estate Equities, Inc., et al. [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Alexandria Real Estate Equities, Inc. due to allegations of violations of federal securities laws, particularly concerning misleading statements about the company's Long Island City property and its financial performance [4][6]. Group 1: Legal Investigation - The firm is encouraging investors who suffered losses in Alexandria between January 27, 2025, and October 27, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Alexandria, with a deadline of January 26, 2026, for investors to seek the role of lead plaintiff [4][8]. - The complaint alleges that Alexandria and its executives made false and misleading statements while concealing material adverse facts about the company's property [6]. Group 2: Financial Performance - Alexandria reported third-quarter earnings on October 27, 2025, which fell short of analyst expectations, showing a 5% decline in revenue and a 7% decline in adjusted funds from operation [7]. - The average occupancy rate for Alexandria decreased from 94.8% in the previous year to 91.4% [7]. - Following the disappointing financial results, Alexandria's stock price dropped over 19% on October 28, 2025 [7].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Alexandria Real Estate is a real estate investment trust focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Group 3: Financial Performance and Stock Impact - Alexandria Real Estate reported lower-than-expected results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on October 28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - Alexandria Real Estate reported lower-than-expected results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 between October 27 and 28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to a property in Long Island City, New York, indicating lower occupancy rates and slower leasing activity [5][6]. Legal Proceedings - Investors have until January 26, 2026, to request to lead the case in the U.S. District Court for the Central District of California, under the caption Hern v. Alexandria Real Estate Equities, Inc., et al. [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3].

Core Viewpoint - The company Alexandria Real Estate Equities is facing legal action due to allegations of violating federal securities laws by making misleading statements regarding its Long Island City property and its leasing value as part of its Megacampus strategy [2]. Financial Performance - Alexandria reported third quarter earnings for 2025 that did not meet analyst expectations, with a 5% decline in revenue and a 7% decline in adjusted funds from operation [3]. - The average occupancy rate for Alexandria decreased from 94.8% in the previous year to 91.4% [3]. - Following the release of these financial results, Alexandria's stock price dropped over 19% on October 28, 2025 [3]. Legal Proceedings - A lead plaintiff has been appointed in the class action lawsuit, representing the investor with the largest financial interest in the case [4]. - Any member of the putative class can move to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [4]. Whistleblower Information - The law firm Faruqi & Faruqi encourages individuals with information regarding Alexandria's conduct, including whistleblowers and former employees, to come forward [5].

SAN DIEGO--(BUSINESS WIRE)---- $ARE #Family--Robbins LLP: Company: Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a real estate investment trust (REIT) specializing in lifescience real estate with a focus on lab space, research facilities and offices for tenants in the pharmaceutical, biotech, and agricultural technology industries. What is the class period? January 27, 2025 - October 27, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all inves ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Alexandria Real Estate Equities, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Alexandria Real Estate Equities securities between January 27, 2025, and October 27, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 26, 2026 [3]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. Group 3: Case Background - The lawsuit alleges that defendants provided misleading information regarding Alexandria Real Estate's expected revenue and funds from operations growth for the 2025 fiscal year, particularly concerning its real estate operations [5]. - Defendants reportedly made positive statements about Alexandria Real Estate's lease activity and occupancy stability while concealing adverse facts about the true state of its Long Island City property [6].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3]. Group 2: Company Performance and Stock Impact - Alexandria Real Estate, a real estate investment trust focused on life science industries, reported lower occupancy rates and slower leasing activity, leading to a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property [4][5]. - On October 27, 2025, the company announced disappointing results for Q3 2025 and reduced guidance for the fiscal year, causing its stock price to drop by $14.93 per share, or over 19%, from $77.87 to $62.94 [6].